Interestingly, it also indicates the need for continuous follow-up of TTP survivors, in line with the International Society of Thrombosis and Hemostasis (ISTH) good practice guidelines, which recommend serial ADAMTS13 activity evaluation every 3–6 months [111]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.